HugoScore hugoscore.org

Patient care navigation and health copilot AI

Advoca

Advoca lets patients and care partners record visits, ask questions, and share information. Its Washington consumer health policy ties free access to research consent, with paid access after withdrawal. The policy and homepage give conflicting accounts of audio processing.

Document-based draft Read full report Open directory

Checklist assessment dated October 30, 2026. Independent confirmation is incomplete. Hugo has not personally verified this service.

Leans expands9 of 12 agency checks metDocument-based draft. Independent confirmation incomplete; not product-tested.How categories work

Agency checklist · October 30, 2026

Leans expands 9 of 12 yes

Document-based draft. Independent confirmation is incomplete. Hugo has not personally verified this service.

Assessed function: Patient/carer-selected Advoca app for recording, preparation, health questions and research participation. Vendor-hosted, with a distinct research-commercialization channel.

Astra review conflicted: OpenAI model in role record.

A no can mean missing documentation or institution-dependent control; it does not by itself establish harmful behavior. These categories are not clinical safety or product-quality ratings.

  • Public documents do not establish actual product behavior.
  • The independent review screened rules and selected evidence; it did not replicate all twelve answers for this tool.
See all twelve answers and their evidence
QuestionAnswerEvidence / reviewSource and reasoning
1. Told it is AIYesdocumented
Not independently replicated
AI-generated summaries of your appointments in simple language, created from the verified transcripts. Source

Privacy Policy and the Consumer Health Data policy both describe LLM-generated summaries and an LLM chatbot.

2. Operator and model maker namedYesdocumented
Not independently replicated
We use Amazon Web Services, Google Cloud Platform, and OpenAI to process audio or transcripts and generate summaries. Source

Operator Advoca Health Ltd (Companies House 16650138). Same section says these providers also perform the chatbot LLM inference under zero data retention.

3. Patient chooses to use itYesdocumented
Not independently replicated
Your explicit, informed consent obtained through the App before you can use these features. Source

Section 3(a), US legal basis. Patient or carer installs the app and consents in a consent flow.

4. Patient sets the taskYesdocumented
Not independently replicated
Plan your notes beforehand with appointment planning, record the conversation on the day, and get a clear, sectioned summary afterwards Source

Patient chooses recording, journal, chat topics and plans. Advoca also runs in-house analysis to identify research opportunities (3(g)) and markets a research reward, which is a secondary operator goal.

5. Patient can decline or stopYesdocumented
Not independently replicated
Your explicit, informed consent obtained through the App before you can use these features. Source

Self-started: Q3 is yes and no care depends on using Advoca. Source is the Q3 source. Account can be deleted at any time and research community is optional.

6. Patient sees the AI outputYesdocumented
Not independently replicated
AI-generated summaries of your appointments in simple language, created from the verified transcripts. Source

Transcripts, summaries and chat answers are shown to the user. Audio is not stored on servers.

7. Patient can correct or challengeNonot-documented
Corrected after independent review; accepted by editor
Your Data Rights (UK and EU Users) Source

The output-rectification right is under UK/EU rights, with a separate California provision; a universal route is not established.

8. Patient can get a copyYesdocumented
Not independently replicated
You can request a copy of all data associated with your account Source

Section 7 says machine-readable format via the application. Home page: 'Export or delete it anytime'.

9. Patient can deleteYesdocumented
Not independently replicated
You can delete all data associated with your account (appointment data, profile health data, personal data, and account data). Source

Specific appointment data can also be deleted in the app, which revokes shared access. Inactive accounts are removed after 2 years.

10. Training or sale does not override patient choiceYesdocumented
Not independently replicated
Joining Advoca’s research community is optional for all users. You can use Advoca without joining. Source

AI training on anonymised data and partner sharing occur only with separate opt-in consent, withdrawable at any time. Policy says Advoca does not sell personal data. Separate caveat: product-improvement analytics, including health journal and chat content, run through PostHog for all users with no opt-out.

11. Patient can run it or take it elsewhereNonot-documented
Not independently replicated
Quotation not recorded; evidence repair pending. Source

Vendor-hosted. Copy of data on request only. No self-hosting or documented move-elsewhere route.

12. No advertising or data businessNodocumented
Not independently replicated
your data will be fully anonymised and may be used for research, development, and commercial purposes. Source

Opt-in community consent allows anonymised data to be shared with trusted partners for commercial purposes. The Life Sciences page offers 'Real-world evidence from our patient community' and the home page promises a share of rewards on study matches. Advertising attribution data goes to Airbridge and Meta (not health data).

Initial coding: Claude Sonnet helpers, compiled by Claude Opus 5.5 (Anthropic). Selective review and corrections: GPT-6 Astra (OpenAI). Editor: Hugo Campos. Acceptance of corrections is not product verification.

Checklist rules · Independent review and limitations · Later evidence follow-up

Earlier v1.3 assessment and control finding

Historical assessment under different rules. It does not set the current checklist zone.

Leans expandsEarlier review, before the published method. Documents only.

Agency finding, before method v1.3

Potentially agency-expanding, with research-access and processing qualifications

Legacy editorial placement, pre-method: 84

This profile has not yet been reviewed under the published method. Its finding and any number are editorial placements made before the method existed.

Evidence
Documentary review. Public sources only, no hands-on testing by HugoScore.
Review status
AI draft. No person has settled the findings.
The question we ask Who does Advoca serve in this deployment?
Control Patient/carer-selected Advoca app for recording, preparation, health questions and research participation. Vendor-hosted, with a distinct research-commercialization channel.
Agency read Leans expands
Vendor
Advoca Health
Who it serves
Potentially patient-directed
Primary User
Cancer patients, rare disease patients, carers, and people managing complex care journeys
Control Model
Vendor-hosted public service. Controls and downstream processors depend on the assessed deployment.
Patient Impact
Source-linked answers and retained originals could help users check summaries and prepare challenges. Actual source matching and correction are untested.
Profile Status
Document-based draft
Last assessed
Oct 30, 2026
Earlier review confidence
Medium for published conditions, low for implementation (AI-assisted draft)
Earlier review model
OpenAI Codex / GPT-6
Earlier human review record
Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.

Earlier evidence and assessment

The sections below preserve the earlier review. Its classifications and provenance are historical; the checklist above gives the current draft classification.

Earlier finding · Legacy editorial placement, pre-method: 84

Method v1.3. The control line is evidence for how the agency finding arose, not a quality score. Legacy editorial placement, pre-method: 84. Not comparable with v1.3 positions.

Potentially agency-expanding, with research-access and processing qualifications

Advoca lets patients and care partners record visits, ask questions, and share information. Its Washington consumer health policy ties free access to research consent, with paid access after withdrawal. The policy and homepage give conflicting accounts of audio processing.

Patient agency

How this tool changes agency

Expands agency when

Source-linked answers and retained originals could help users check summaries and prepare challenges. Actual source matching and correction are untested.

Limits agency when

Whether the tier conditions apply identically outside Washington, actual audio routing, transcript correction, and post-anonymization withdrawal effects.

Patient agency assessment

Who sets and changes the goal?

Patient authority

Patients choose questions, records, and recipients. Consent withdrawal is documented but has a financial consequence for free-tier users. That is a substantive condition on continued access, not simply optional research alongside identical free service.

What can the patient understand, question, or do?

Critical capacity

Source-linked answers and retained originals could help users check summaries and prepare challenges. Actual source matching and correction are untested.

Can the patient evaluate the conditions of use?

Informed control

The detailed policy enables scrutiny, but its account of processing differs from a prominent privacy promise. Research consent and model-training use should be visible before reliance.

Text findings

Conditions of use

Published controls and their limits

The detailed policy enables scrutiny, but its account of processing differs from a prominent privacy promise. Research consent and model-training use should be visible before reliance.

What remains unknown?

Not tested or not established

Whether the tier conditions apply identically outside Washington, actual audio routing, transcript correction, and post-anonymization withdrawal effects.

Who evaluated this?

AI-assisted public-source draft

Vendor statements describe published conditions, not independently verified behavior. No clinical, security, accessibility, or legal validation is claimed. Earlier evidence remains dated in the report and history.

Sources checked

Source-specific findings and retrieval limitations are recorded in the full report.

Earlier review provenance

Criteria

CAIHL-derived HugoScore framework and September 7 qualitative review priorities. Draft v1.2 numerical anchors remain unadopted.

Reviewer

AI-assisted public-source reassessment prepared in OpenAI Codex.

AI / model

OpenAI Codex / GPT-6

Human review

Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.

Review date

2026-09-08

Limitations

Whether the tier conditions apply identically outside Washington, actual audio routing, transcript correction, and post-anonymization withdrawal effects. No live product use, patient-data upload, account creation, code audit, clinical evaluation, or independent implementation validation.

Earlier review method

Focused public-source reassessment using CAIHL: patient authority, critical capacity, and informed control. Existing evidence plus one focused primary-source pass and at most one targeted follow-up. No live product testing. Numerical scores remain provisional editorial placements, not a new calculation.

Document-based draft · Medium for published conditions, low for implementation (AI-assisted draft)